Research has shown 2’-FL to have a number of important functions, the two most important of which are the bifidogenic effect4-5 and anti-pathogenic effects 2-3. Additional benefits described are reducing the risk of allergy6-7, anti-inflammatory effects9, affecting brain development10-11, affecting gut maturation and gut barrier function8. Any potential benefit for consumers should not be considered a health claim, but may be used in the development of potential health claims in strict compliance with local legal requirements.
The first HMO FrieslandCampina Ingredients offers is Aequival® 2’-FL. Aequival® 2′-FL is structurally identical to the 2′-fucosyllactose (2′-FL) component naturally present in human milk. 2′-FL is the most prevalent human milk oligosaccharide. As there are more than 200 different varieties of HMOs, FrieslandCampina Ingredients is developing a range of HMOs that will be commercially available in the foreseeable future.